Research on pain-relieving drugs. Covers new pain-management startups, omega-3 approaches, drug safety, and AI-driven drug discovery.
A recent study published in Annals of Emergency Medicine found no correlation between painkillers, including opiates, and patient satisfaction scores in emergency departments. Instead, factors such as increasing age and male gender were linked to higher satisfaction scores.
A new microfluidic method simulates blood flowing through narrowed coronary arteries to evaluate anti-clotting drugs like aspirin. The study found that while aspirin can prevent dangerous clots in some patients, it may not be effective for those with narrowed arteries.
Breast cancer is a significant global health issue, with over 1.6 million new cases diagnosed annually. The disease disproportionately affects low-income countries, where late-stage diagnosis and limited treatment options contribute to high mortality rates.
Researchers create experimental substances based on a tiny protein found in cone snail venom that could lead to the development of safe and effective oral medications for chronic nerve pain. The new substances are about 100 times more potent than morphine or gabapentin, with fewer side effects and lower risk of abuse.
Researchers found a dramatic rise in opioid analgesic prescriptions during US emergency department visits from 2001 to 2010, with some opioids increasing by 668.2 percent. Despite modest increases in painful conditions, the findings suggest a concerning trend that may lead to misuse and addiction.
Researchers at North Carolina State University have developed a new trial design to counter the caregiver placebo effect in veterinary medicine. The study found that a low-dose pain medication was effective in cats with degenerative joint disease, despite owners' initial perceptions of improvement due to the placebo effect.
Researchers found that opioid prescriptions stabilized after tripling between 1999 and 2008, but the impact of prescription drug monitoring programs (PDMPs) varies significantly by state. Nine states showed significant decreases, while eight experienced increases in MMEs dispensed per capita.
Patients with rheumatic conditions are turning to herbal cannabis for symptom relief, but medical evidence is lacking. The study advises healthcare providers to discourage patients from using this drug as therapy due to potential harm and availability of other therapies.
A new approach to breast reconstruction surgery, known as an enhanced recovery pathway, has been shown to reduce opioid painkiller use in patients by 50% and decrease hospital stays by a day on average. The method includes preoperative analgesics, nonsteroidal anti-inflammatories, and resuming food and walking soon after surgery.
Scientists at LMU developed photoreactive compounds that modulate nerve-cell function, opening new routes to treat neurological diseases like chronic pain and visual impairment. They created hybrid photoreceptors that respond to light, potentially leading to new therapies for these conditions.
Research from Oregon State University finds that low birth weight individuals have impaired kidney function, affecting drug excretion and metabolism. This may lead to reduced effectiveness of medications in treating diseases such as diabetes and hypertension.
Researchers at UCLA found a significant link between the use of acetaminophen during pregnancy and an increased risk of attention-deficit/hyperactivity disorder (ADHD) in children. The study, which examined data from over 64,000 mothers and their children, suggests that long-term acetaminophen use may disrupt fetal brain development an...
New research reveals that opioid use changes the activity of a specific protein needed for normal brain function, affecting both pain relief and tolerance. The study found that blocking this protein can reduce addiction-related behaviors, but increasing its activity lowers pain relief response and leads to faster morphine tolerance.
A study of 64,322 children found that mothers who used acetaminophen during pregnancy were at higher risk for their children developing ADHD-like behaviors and hyperkinetic disorders. The use of acetaminophen in multiple trimesters increased the risk further.
Chronic musculoskeletal pain affects an estimated 100 million Americans, with low back pain and degenerative joint processes being common causes. Non-steroidal anti-inflammatory drugs (NSAIDs) are not effective in many chronic pain scenarios, but antidepressants and anticonvulsants can provide remarkable relief.
A new study of 11,000 teenagers found that combining school-based Life Skills Training with home-based Strengthening Families program significantly reduced prescription drug abuse rates by 10%. The six-year study also identified the most cost-effective programs, with Life Skills Training costing just $15 per child.
A new tool, Conjunctive Exploratory Navigation Interface (CENI), combines two search modes to provide a more focused search and retrieve the most pertinent information. CENI outperformed traditional keyword-based lookup interfaces in a study involving crowdsourced testers.
A year-long study found that pregabalin reduced RLS symptoms and was less likely to cause worsening symptoms compared to pramipexole. Dopaminergic drugs were associated with symptom augmentation in some patients, highlighting the need for caution when treating RLS patients.
University of Adelaide researchers have identified a crucial mechanism that can prevent liver failure resulting from excessive paracetamol consumption. By targeting the transient receptor potential melanostatine-2 (TRPM2) channel, they hope to develop new treatments for paracetamol overdose and potentially other liver-damaging poisonings.
A new drug treatment has been found to be effective against chronic pain caused by nerve damage, including post-herpetic neuralgia. Fifty-eight per cent of participants taking the drug found it effective, reducing pain by at least 30 per cent.
Handwashing and zinc are likely effective in preventing colds, with some evidence suggesting they also work for adults. Antihistamines combined with decongestants and pain medications can provide relief from symptoms, while ibuprofen and acetaminophen help with pain and fever.
Researchers found a significant inverse association between aspirin use and vestibular schwannoma growth in a retrospective series of 689 people. Aspirin intake may inhibit tumor growth, providing a potential therapeutic role for this anti-inflammatory medication.
Scientists have identified a 'brake' ion channel TREK2 in sensory neurons that limits spontaneous pain by stabilizing membrane potential. This discovery may lead to new pain relief treatments for conditions like neuropathic pain.
Researchers at UD developed a smart hydrogel that delivers medicine in response to mechanical force, reducing inflammation and pain in osteoarthritis. Preliminary results indicate biocompatibility and potential applications beyond osteoarthritis.
A study published in Nature Chemical Biology found that a molecular switch in the nerves responsible for detecting pain can 'short-circuit', intensifying pain. This alternative pathway activates the pain nerves, increasing the sensation of pain.
Researchers at Scripps Research Institute describe two new drug scaffolds that target the kappa opioid receptor, offering novel tools for treating pain, addiction, and other disorders. The compounds, called biased agonists, activate the receptor without recruiting beta arrestin, a molecule associated with depression.
Researchers discovered how sodium controls opioid receptors, a major class of brain cell receptors. The findings suggest new therapeutic approaches to treat pain and mood disorders. Sodium's effect on receptor activity is crucial for developing better opioid-receptor-targeting drugs.
Researchers at the University of Missouri have developed a comprehensive, nonsurgical treatment that significantly improves symptoms of pelvic floor dysfunction in women. The treatment involves muscle strengthening and relaxation techniques, resulting in an average 80% improvement in urinary incontinence, defecatory dysfunction, and pe...
A study by Beth Israel Deaconess Medical Center found that patients' expectations, whether positive, negative, or neutral, significantly influence the effects of both medications and placebos on migraine pain. The researchers discovered that a positive message and powerful medication are essential for effective clinical care.
Researchers at University of Nottingham discovered a potential drug to reduce osteoarthritis pain by targeting cannabinoid receptor2 (CB2), which also reduces joint inflammation. The synthetic compound JWH133 showed promise in animal models and human spinal cord tissue studies.
Research finds mTOR activation in neurons of dorsal horn contributes to morphine tolerance and hyperalgesia; rapamycin treatment improves opioid tolerance and hyperalgesia in rats. Targeting the mTOR pathway may enhance pain management.
Researchers from the University of California, Irvine, have identified a new natural compound in a traditional Chinese medicine plant that relieves chronic pain. The compound, dehydrocorybulbine (DHCB), acts on dopamine receptors and shows promise for treating low-level chronic pain without losing effectiveness over time.
Researchers discovered a compound in traditional Chinese herbal medicine that effectively alleviates both inflammatory and nerve pain, with no tolerance to addiction. The compound, dehydrocorybulbine, was found to be reproducible and has potential as a new nonaddictive treatment for chronic neuropathic pain.
A recent study led by Boston University School of Medicine researchers found that diflunisal successfully reduced neurological decline and preserved quality of life in patients with familial transthyretin amyloidosis. This repurposed generic drug demonstrates an effective alternative to liver transplantation for this devastating disease.
Researchers at Umeå University detected measurable concentrations of illicit drugs in Swedish wastewater from 33 treatment plants. The study found 13 different narcotic substances, with oxazepam, codeine, and morphine being the most common prescription drug residues.
A large study found that patients receiving etomidate for anesthesia may be at increased risk of mortality and cardiovascular events, with a 250% increase in death risk compared to those receiving propofol. The results have sparked concerns over the safety of etomidate use.
A study by Dana-Farber Cancer Institute and Yale University found that moderate daily exercise can decrease joint pain in postmenopausal women taking aromatase inhibitors for breast cancer. After a year, joint pain scores decreased by 20% in the exercise group compared to 3% in the non-exercise group.
The American College of Physicians recommends clinical and administrative changes to deter prescription drug abuse while maintaining patient access to treatment. The guidelines advocate for physician, patient, and public education on the harms of medical and nonmedical use of prescription drugs.
The study examined changes in brain functional activity and central networks in subjects with migraine undergoing acupuncture at Shaoyang uncommon acupoints. Acupuncture has been shown to be a recommended treatment for migraine sufferers, but the central analgesic mechanism remains poorly understood.
A new study suggests that vaginal administration of erectile dysfunction medication sildenafil citrate may alleviate moderate to severe menstrual cramps with no reported side effects. Researchers found that the drug relieved pain by increasing blood flow, but the exact mechanism remains unknown.
Researchers have determined the structure of TRPV1, a protein that plays a central role in pain perception and heat sensation, at near-atomic resolution using electron cryo-microscopy. This breakthrough offers fresh insights to drug designers searching for new pain treatments and sheds light on the protein's unique properties.
Researchers found that oxycodone is the most popular drug due to its high quality, while hydrocodone remains a favorite despite lower euphoric qualities. Hydrocodone's popularity stems from its affordability, ease of access, and perceived safety, making it an attractive option for risk-averse users.
A global survey by the European Society for Medical Oncology found that over half of the world's population lives in countries with regulations limiting access to opioid medicines for managing cancer pain. The study highlights the need for regulatory reform and education to improve access to these medicines.
A study found that people taking statin drugs often take an average of three other medications that can cause muscle pain and lead to discontinued use, a major contributor to the side effect. Researchers recommend adjusting dosages or choosing alternative medications to minimize interactions.
Researchers discovered that Δ9-THC causes an increase in COX-2 levels, leading to memory impairments. Taking an over-the-counter painkiller like ibuprofen can prevent these side effects by inhibiting COX-2 levels.
Taking aspirin at bedtime instead of in the morning could reduce acute heart events by reducing platelet activity. A randomized study found that taking aspirin at bedtime resulted in a 22-unit reduction in platelet activity compared to taking it in the morning.
Researchers used brain imaging to track pregabalin's effects on fibromyalgia patients, finding reduced glutamate levels and decreased insula connectivity. This study suggests a future of targeted brain imaging approaches for chronic widespread pain treatment.
A study analyzing over 1 million hospital admissions found that over 50% of nonsurgical patients were prescribed opioids, with high doses and late discharge increasing the risk of adverse events. Regional variation in prescribing rates was also observed, with a 37% difference between the highest and lowest regions.
A new study reveals a sharp rise in US drug poisoning deaths by county, with both urban and rural areas experiencing significant increases. Rural areas showed a greater percentage increase in death rates, highlighting the need for targeted policies and programs to address this growing public health concern.
A study by CU-Boulder researchers found that using morphine to treat post-operative pain after abdominal surgery can actually prolong recovery time and increase suffering. The scientists discovered that both morphine and the surgery itself activate glial cells, leading to additional pain signals.
Patients should never drive if taking narcotic pain medication, as it impairs cognitive judgment and reaction time. Additionally, using one arm can significantly limit safe driving abilities due to impaired coordination and control of the vehicle.
A clinical trial found gabapentin to be safe and effective in treating alcohol dependence, reducing cravings, depression, and sleeplessness. The drug's effect on drinking outcomes was at least as large as existing FDA-approved treatments, with significant benefits seen in patients who received the high-dose regimen.
A University of Southampton study has found that ibuprofen provides no benefit for patients with respiratory tract infections, including colds and sore throats. The research also showed that steam inhalation has no clear symptom-relieving effect, while ibuprofen may actually contribute to the progression of illness in some individuals.
A study published in Journal of General Internal Medicine found that long-term opioid use is linked to a higher risk of developing major depression. Patients who used opioids for 180 days or longer were at a 53% increased risk, while those using them for 90-180 days had a 25% increased risk.
Researchers develop a new molecule combining elements of Botox and tetanus toxin to alleviate inflammatory pain, offering potential relief for chronic pain conditions and epilepsy. The engineered molecule could improve quality of life for those suffering from chronic pain with a single injection providing prolonged pain relief.
A new study suggests that prenatal exposure to paracetamol may increase the risk of adverse effects on child development, including poorer gross motor skills and behavioral problems. The study found that occasional use for short periods is likely not harmful to the fetus, but more research is needed to confirm these results.
A new University of Michigan study finds that 10.4% of teens and young adults treated in the emergency room admitted to misusing prescription painkillers or sedatives at least once in the last year. The study suggests that emergency departments could be an effective setting for screening and intervening early before problems arise.
A study of liposomal bupivacaine found it produces femoral nerve block lasting longer than 24 hours in volunteers, but the results are not straightforward due to variable responses and an inverse relationship between dose and response. Larger trials will be needed before the product can be recommended for routine clinical use.
Remimazolam, a benzodiazepine-type sedative drug, has shown promising results as an alternative to conventional sedatives in colonoscopy procedures. The medication provides adequate sedation with a fast onset and quick recovery time, making it a valuable option for patients undergoing brief medical procedures.
A new drug, Linaclotide, has been found to effectively relieve abdominal pain in IBS-C patients through a novel physiological pathway. The study's findings provide significant relief for approximately one-third of IBS-C sufferers who have struggled with this debilitating condition.